Gut Microbiota and Biomarkers of Intestinal Barrier Damage in Cirrhosis
Microorganisms · 25.02.2024 · 12 (3) · 463
DOI: 10.3390/microorganisms12030463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 25.02.2024. Verfasst von Irina Efremova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119991, Russia. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gut dysbiosis and subclinical intestinal damage are common in cirrhosis. The aim of this study was to examine the association of intestinal damage biomarkers (diamine oxidase [DAO], claudin 3, and intestinal fatty acid binding protein [I-FABP; FABP2]) with the state of the gut microbiota in cirrhosis. The blood levels of DAO were inversely correlated with blood levels of claudin 3, lipopolysaccharide (LPS), presepsin, TNF-α, and the severity of cirrhosis according to Child–Pugh scores. The blood level of I-FABP was directly correlated with the blood level of claudin 3 but not with that of DAO. Patients with small intestinal bacterial overgrowth (SIBO) had lower DAO levels than patients without SIBO. There was no significant difference in claudin 3 levels and I-FABP detection rates between patients with and without SIBO. The DAO level was directly correlated with the abundance of Akkermansiaceae, Akkermansia, Allisonella, Clostridiaceae, Dialister, Lactobacillus, Muribaculaceae, Negativibacillus, Ruminococcus, Thiomicrospiraceae, Verrucomicrobiae, and Verrucomicrobiota; and it was inversely correlated with the abundance of Anaerostipes, Erysipelatoclostridium, and Vibrio. The I-FABP level was directly correlated with Anaerostipes, Bacteroidia, Bacteroidota, Bilophila, Megamonas, and Selenomonadaceae; and it was inversely correlated with the abundance of Brucella, Pseudomonadaceae, Pseudomonas, and Vibrionaceae. The claudin 3 level was directly correlated with Anaerostipes abundance and was inversely correlated with the abundance of Brucella, Coriobacteriia, Eggerthellaceae, and Lactobacillus.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119991, Russia.
- The Interregional Public Organization "Scientific Community for the Promotion of the Clinical Study of the Human Microbiome", Moscow 119435, Russia.
- Pharmacology Department, Lomonosov Moscow State University, Leninskie Gori 1, Moscow 119991, Russia.
- Post-Genomic Research Laboratory, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilova Str. 32, Moscow 119991, Russia.
- V.A. Nasonova Research Institute of Rheumatology, Kashirskoye Shose 34A, Moscow 115522, Russia.
ORCID-Profile: Roman Maslennikov, Oleg Medvedev, Anna Kudryavtseva, Anastasia Avdeeva, George Krasnov, Maria Fedorova
Zitieren
APA
Efremova, I., Maslennikov, R., Medvedev, O., Kudryavtseva, A., Avdeeva, A., Krasnov, G., Romanikhin, F., Diatroptov, M., Fedorova, M., Poluektova, E., Levshina, A., & Ivashkin, V. (2024). Gut Microbiota and Biomarkers of Intestinal Barrier Damage in Cirrhosis. Microorganisms, 12(3), 463. https://doi.org/10.3390/microorganisms12030463
Vancouver
Efremova I, Maslennikov R, Medvedev O, Kudryavtseva A, Avdeeva A, Krasnov G, et al. Gut Microbiota and Biomarkers of Intestinal Barrier Damage in Cirrhosis. Microorganisms. 2024;12(3):463. doi:10.3390/microorganisms12030463
BibTeX
@article{Efremova2024,
author = {Efremova, Irina and Maslennikov, Roman and Medvedev, Oleg and Kudryavtseva, Anna and Avdeeva, Anastasia and Krasnov, George and Romanikhin, Filipp and Diatroptov, Mikhail and Fedorova, Maria and Poluektova, Elena and Levshina, Anna and Ivashkin, Vladimir},
title = {Gut Microbiota and Biomarkers of Intestinal Barrier Damage in Cirrhosis},
journal = {Microorganisms},
year = {2024},
volume = {12},
number = {3},
pages = {463},
doi = {10.3390/microorganisms12030463}
}
EUVIMED